KYRivianMan
Member
Updated Release notes on Novo’s Cargi/ Sema Blend Study stating that when Cagrilintide and Semaglutide are combined into one formulation they don’t stay stable. This requires each molecule to be held in dual chambers in order to stay stable. UNTIL Today they are testing a two different singular formulations and will release results from new study once complete. So… I am wondering that the Cagri/Sema blend being offered by vendors is even effective. They should be pinned separately. What is everyone’s thoughts?